I Schönborn
- Molecular Biology
- Oncology
- Reproductive Medicine top 5%
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- C. MinguillonW. LichteneggerAngela RelesMichael F. PressIngo B. RunnebaumAnnette SchmiderConway GeeLovell A. Jones
- Topics
- HER2/EGFR in Cancer Research (6 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Radiopharmaceutical Chemistry and Applications (2 papers)
- Journals
- Cancer LettersInternational Journal of OncologyClinical Chemistry and Laboratory Medicine (CCLM)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
I Schönborn
13 papers receiving 368 citations
Peers
Comparison fields: 5 of 52
- Molecular Biology 223
- Oncology 176
- Reproductive Medicine 102
- Cancer Research 87
- Pathology and Forensic Medicine 54
Countries citing papers authored by I Schönborn
This map shows the geographic impact of I Schönborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Schönborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Schönborn more than expected).
Fields of papers citing papers by I Schönborn
This network shows the impact of papers produced by I Schönborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Schönborn. The network helps show where I Schönborn may publish in the future.
Co-authorship network of co-authors of I Schönborn
This figure shows the co-authorship network connecting the top 25 collaborators of I Schönborn. A scholar is included among the top collaborators of I Schönborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Schönborn. I Schönborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. | 228 |
| 4 | Expression of E-cadherin and catenins in invasive mammary carcinomas. | 82 |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors. | 3 |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 11 | |
| 13 | [Importance of PCNA proliferating fraction and histomorphologic prognostic factors for survival in breast cancer]. | 3 |
| 14 | 4 |
About I Schönborn
I Schönborn is a scholar working on Developmental Biology, Oncology and Reproductive Medicine, having authored 14 papers that have together received 373 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Reproductive Medicine (102 citations), Oncology (176 citations) and Cancer Research (87 citations). I Schönborn has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include C. Minguillon, W. Lichtenegger, Angela Reles, Michael F. Press, Ingo B. Runnebaum, Annette Schmider, Conway Gee, Lovell A. Jones, Adel K. El‐Naggar and Olaf Reich. Their work appears in journals such as Cancer Letters, International Journal of Oncology and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.